Wait, we have a special offer for you! ✋

Get your exclusive discount now

Use FY25SAVE to get flat 20% off on the report No, I'd pay the full price

Terms & Conditions : This coupon is vaild exclusively for Global Market Reports 2025 and can be used Until March 31 , 2025 .

Global Roxadustat Market Report 2025

Roxadustat Global Market Report 2025 - By Type (20mg, 50mg), By Product Formulation (Oral Tablets), By Distribution Channel (Hospitals, Specialty Pharmacies, Dialysis Centers), By End-User Application (Chronic Kidney Disease-Associated Anemia, Other Anemia Conditions) - Market Size, Trends, And Global Forecast 2025-2034

Roxadustat Global Market Report 2025

Report Price : $4490.00 | Pages : 175 | Published : March 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Roxadustat Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

What Is Covered Under Roxadustat Market

Roxadustat is an orally administered hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI) that stabilizes hypoxia-inducible factors, leading to increased erythropoietin production, enhanced iron absorption, and improved hemoglobin synthesis without the need for exogenous erythropoiesis-stimulating agents. It is used to manage anemia by addressing low hemoglobin levels in patients with chronic kidney disease and potentially other conditions involving impaired red blood cell production.

The main types in Roxadustat are 20 mg and 50 mg. 20 mg Roxadustat is an oral hypoxia-inducible factor-prolyl hydroxylase (HIF-PH) inhibitor used for treating anemia associated with chronic kidney disease by stimulating endogenous erythropoietin production. The product formulation of this is oral tablets, which are distributed by various channels such as hospitals, specialty pharmacies, and dialysis centers. Roxadustat is used in chronic kidney disease-associated anemia and others.

How Is The Roxadustat Market Segmented?

The roxadustat market covered in this report is segmented –

1) By Type: 20mg, 50mg

2) By Product Formulation: Oral Tablets

3) By Distribution Channel: Hospitals, Specialty Pharmacies, Dialysis Centers

4) By End-User Application: Chronic Kidney Disease-Associated Anemia, Other Anemia Conditions

Subsegments:

1) By 20mg: Oral Tablets, Injectable Formulations

2) By 50mg: Oral Tablets, Injectable Formulations

Roxadustat Market Size and growth rate 2025 to 2029: Graph

What Is The Roxadustat Market Size 2025 And Growth Rate?

The Roxadustat market size has grown strongly in recent years. It will grow from $6.44 billion in 2024 to $6.92 billion in 2025 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to regulatory approvals in major markets, strong clinical trial results, increasing prevalence of chronic kidney disease, growing awareness of anemia management, and government support for anemia treatments.

What Is The Roxadustat Market Growth Forecast?

The Roxadustat market size is expected to see strong growth in the next few years. It will grow to $9.16 billion in 2029 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to ongoing research for new indications, increasing healthcare expenditure, demand for non-injectable anemia treatments, expanding reimbursement policies, and rising geriatric population. Major trends in the forecast period include a shift towards oral anemia treatments, increasing competition from alternative therapies, expansion of licensing agreements, growing investment in hypoxia-inducible factor research, and a focus on patient-centric treatment approaches.

Book your 30 minutes free consultation with our research experts

Contact Us

What Is Driving The Roxadustat Market: Impact Of Rising Chronic Kidney Disease Cases On The Growth Of The Market

The rising number of people with chronic kidney disease (CKD) is expected to propel the growth of the Roxadustat market going forward. Chronic kidney disease (CKD) is a long-term condition where the kidneys gradually lose their ability to function properly, often leading to kidney failure if left untreated. The number of people affected by chronic kidney disease is rising globally due to factors such as aging populations, increasing rates of diabetes, hypertension, and unhealthy lifestyles. Roxadustat helps manage chronic kidney disease by stimulating the production of erythropoietin, which increases red blood cell production and helps address anemia commonly associated with the condition, thereby improving overall kidney function and quality of life for patients. For instance, in December 2024, according to a report published by the Australian Institute of Health and Welfare (AIHW), an Australia-based government agency, the mortality rates for chronic kidney disease experienced a modest annual rise, increasing by 4.2% in 2021 and 6.2% in 2022. Therefore, the rising number of people with chronic kidney disease (CKD) is driving the growth of the Roxadustat market.

Who Are The Major Players In The Global Roxadustat Market?

Major companies operating in the roxadustat market are AstraZeneca PLC, Viatris Inc., Astellas Pharma Inc., Dr. Reddy's Laboratories Ltd., Hetero Drugs Limited, Akebia Therapeutics Inc., Metrochem API Private Limited, FibroGen Inc., AMI Lifesciences, Lee Pharma Ltd., Faran Shimi Pharmaceutical Company, Maithri Drugs Pvt. Ltd., Clearsynth Labs Ltd., Bal Pharma, HEMA Pharmaceuticals Pvt. Ltd., Zhejiang Hengkang Pharmaceutical Co. Ltd., Kimia Biosciences Pvt. Ltd., Lewens Labs Pvt. Ltd., Hangzhou Longshine Bio-Tech Co. Ltd., GLR Innovations, Suzhou Biosyntech Co. Ltd., Shanvr Life Sciences Pvt. Ltd.

What Are The Key Trends Of The Global Roxadustat Market: Roxadustat Reimbursement Under Ireland’s High Tech Drugs Scheme Accelerates Market Growth

Major companies operating in the Roxadustat market are opting for reimbursement under the high-tech drugs scheme to ensure broader patient access by reducing financial barriers, thereby accelerating market uptake and demonstrating the cost-effectiveness of their innovative therapies. The high-tech drugs scheme is a government-managed program primarily in Ireland that provides reimbursement for the dispensing of expensive, highly specialized medications typically prescribed in hospital settings. For instance, in September 2022, Astellas Pharma Company Ltd., a US-based pharmaceutical company announced that its EVRENZO (Roxadustat) has been granted reimbursement under the High-Tech Drugs Scheme in Ireland. Roxadustat is the first in a new class of orally administered hypoxia-inducible factor prolyl hydroxylase (HIF PH) inhibitors licensed and reimbursed in Ireland. The results showed Roxadustat was effective in achieving and maintaining target hemoglobin levels (10-12g/dL) in patients with symptomatic anemia of CKD, regardless of dialysis status and prior ESA treatment.

What Are Latest Mergers And Acquisitions In The Roxadustat Market: Fibrogen Partners With Astellas Pharma And AstraZeneca For Roxadustat Development And Commercialization

In February 2024, FibroGen Inc., a US-based biopharmaceutical company, announced a partnership with Astellas Pharma Inc. and AstraZeneca PLC. With this collaboration, FibroGen Inc. aims to develop and commercialize Roxadustat for the treatment of anemia in various conditions, including chronic kidney disease (CKD) and myelodysplastic syndromes (MDS). Astellas Pharma Inc. is a Japan-based pharmaceutical company, and AstraZeneca PLC. is a UK-based pharmaceutical company involved in the development and commercialization of Roxadustat.

What Is The Regional Outlook For The Global Roxadustat Market?

North America was the largest region in the Roxadustat market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the roxadustat market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the roxadustat market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Roxadustat  Market?

The Roxadustat market consists of sales of products such as 70 mg, 100 mg, and 150 mg film-coated tablets. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Roxadustat  Industry?

The Roxadustat market research report is one of a series of new reports from The Business Research Company that provides Roxadustat market statistics, including Roxadustat industry global market size, regional shares, competitors with a Roxadustat market share, detailed Roxadustat market segments, market trends and opportunities, and any further data you may need to thrive in the Roxadustat industry. This Roxadustat market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Roxadustat Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 $6.92 billion
Revenue Forecast In 2034 $9.16 billion
Growth Rate CAGR of 7.3% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The roxadustat market covered in this report is segmented –
1) By Type: 20mg, 50mg
2) By Product Formulation: Oral Tablets
3) By Distribution Channel: Hospitals, Specialty Pharmacies, Dialysis Centers
4) By End-User Application: Chronic Kidney Disease-Associated Anemia, Other Anemia Conditions Subsegments:
1) By 20mg: Oral Tablets, Injectable Formulations
2) By 50mg: Oral Tablets, Injectable Formulations
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled AstraZeneca PLC, Viatris Inc., Astellas Pharma Inc., Dr. Reddy's Laboratories Ltd., Hetero Drugs Limited, Akebia Therapeutics Inc., Metrochem API Private Limited, FibroGen Inc., AMI Lifesciences, Lee Pharma Ltd., Faran Shimi Pharmaceutical Company, Maithri Drugs Pvt. Ltd., Clearsynth Labs Ltd., Bal Pharma, HEMA Pharmaceuticals Pvt. Ltd., Zhejiang Hengkang Pharmaceutical Co. Ltd., Kimia Biosciences Pvt. Ltd., Lewens Labs Pvt. Ltd., Hangzhou Longshine Bio-Tech Co. Ltd., GLR Innovations, Suzhou Biosyntech Co. Ltd., Shanvr Life Sciences Pvt. Ltd.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Roxadustat Market Characteristics

    3. Roxadustat Market Trends And Strategies

    4. Roxadustat Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

    5. Global Roxadustat Growth Analysis And Strategic Analysis Framework

    5.1. Global Roxadustat PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    5.2. Analysis Of End Use Industries

    5.3. Global Roxadustat Market Growth Rate Analysis

    5.4. Global Roxadustat Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

    5.5. Global Roxadustat Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

    5.6. Global Roxadustat Total Addressable Market (TAM)

    6. Roxadustat Market Segmentation

    6.1. Global Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20mg

    50mg

    6.2. Global Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Oral Tablets

    6.3. Global Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Hospitals

    Specialty Pharmacies

    Dialysis Centers

    6.4. Global Roxadustat Market, Segmentation By End-User Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Chronic Kidney Disease-Associated Anemia

    Other Anemia Conditions

    7. Roxadustat Market Regional And Country Analysis

    7.1. Global Roxadustat Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    7.2. Global Roxadustat Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8. Asia-Pacific Roxadustat Market

    8.1. Asia-Pacific Roxadustat Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.3. Asia-Pacific Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.4. Asia-Pacific Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    9. China Roxadustat Market

    9.1. China Roxadustat Market Overview

    9.2. China Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.3. China Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.4. China Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    10. India Roxadustat Market

    10.1. India Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.2. India Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.3. India Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11. Japan Roxadustat Market

    11.1. Japan Roxadustat Market Overview

    11.2. Japan Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.3. Japan Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.4. Japan Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12. Australia Roxadustat Market

    12.1. Australia Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.2. Australia Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.3. Australia Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13. Indonesia Roxadustat Market

    13.1. Indonesia Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.2. Indonesia Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.3. Indonesia Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14. South Korea Roxadustat Market

    14.1. South Korea Roxadustat Market Overview

    14.2. South Korea Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.3. South Korea Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.4. South Korea Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15. Western Europe Roxadustat Market

    15.1. Western Europe Roxadustat Market Overview

    15.2. Western Europe Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.3. Western Europe Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.4. Western Europe Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16. UK Roxadustat Market

    16.1. UK Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.2. UK Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.3. UK Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17. Germany Roxadustat Market

    17.1. Germany Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.2. Germany Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.3. Germany Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18. France Roxadustat Market

    18.1. France Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.2. France Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.3. France Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19. Italy Roxadustat Market

    19.1. Italy Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.2. Italy Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.3. Italy Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20. Spain Roxadustat Market

    20.1. Spain Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.2. Spain Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.3. Spain Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21. Eastern Europe Roxadustat Market

    21.1. Eastern Europe Roxadustat Market Overview

    21.2. Eastern Europe Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.3. Eastern Europe Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.4. Eastern Europe Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22. Russia Roxadustat Market

    22.1. Russia Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.2. Russia Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.3. Russia Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23. North America Roxadustat Market

    23.1. North America Roxadustat Market Overview

    23.2. North America Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.3. North America Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.4. North America Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24. USA Roxadustat Market

    24.1. USA Roxadustat Market Overview

    24.2. USA Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.3. USA Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.4. USA Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25. Canada Roxadustat Market

    25.1. Canada Roxadustat Market Overview

    25.2. Canada Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.3. Canada Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.4. Canada Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26. South America Roxadustat Market

    26.1. South America Roxadustat Market Overview

    26.2. South America Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.3. South America Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.4. South America Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27. Brazil Roxadustat Market

    27.1. Brazil Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.2. Brazil Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.3. Brazil Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28. Middle East Roxadustat Market

    28.1. Middle East Roxadustat Market Overview

    28.2. Middle East Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.3. Middle East Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.4. Middle East Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29. Africa Roxadustat Market

    29.1. Africa Roxadustat Market Overview

    29.2. Africa Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.3. Africa Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.4. Africa Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    30. Roxadustat Market Competitive Landscape And Company Profiles

    30.1. Roxadustat Market Competitive Landscape

    30.2. Roxadustat Market Company Profiles

    30.2.1. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis

    30.2.2. Viatris Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.3. Astellas Pharma Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.4. Dr. Reddy's Laboratories Ltd. Overview, Products and Services, Strategy and Financial Analysis

    30.2.5. Hetero Drugs Limited Overview, Products and Services, Strategy and Financial Analysis

    31. Roxadustat Market Other Major And Innovative Companies

    31.1. Akebia Therapeutics Inc.

    31.2. Metrochem API Private Limited

    31.3. FibroGen Inc.

    31.4. AMI Lifesciences

    31.5. Lee Pharma Ltd.

    31.6. Faran Shimi Pharmaceutical Company

    31.7. Maithri Drugs Pvt. Ltd.

    31.8. Clearsynth Labs Ltd.

    31.9. Bal Pharma

    31.10. HEMA Pharmaceuticals Pvt. Ltd.

    31.11. Zhejiang Hengkang Pharmaceutical Co. Ltd.

    31.12. Kimia Biosciences Pvt. Ltd.

    31.13. Lewens Labs Pvt. Ltd.

    31.14. Hangzhou Longshine Bio-Tech Co. Ltd.

    31.15. GLR Innovations

    32. Global Roxadustat Market Competitive Benchmarking And Dashboard

    33. Key Mergers And Acquisitions In The Roxadustat Market

    34. Recent Developments In The Roxadustat Market

    35. Roxadustat Market High Potential Countries, Segments and Strategies

    35.1 Roxadustat Market In 2029 - Countries Offering Most New Opportunities

    35.2 Roxadustat Market In 2029 - Segments Offering Most New Opportunities

    35.3 Roxadustat Market In 2029 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Roxadustat Market, Segmentation By End-User Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Roxadustat Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Roxadustat Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Asia-Pacific, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Asia-Pacific, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Asia-Pacific, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: China, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: China, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: China, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: India, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: India, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: India, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: Japan, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: Japan, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Japan, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Australia, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Australia, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Australia, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Indonesia, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Indonesia, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Indonesia, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: South Korea, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: South Korea, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: South Korea, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Western Europe, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Western Europe, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Western Europe, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: UK, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: UK, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: UK, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Germany, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Germany, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Germany, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: France, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: France, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: France, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Italy, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Italy, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Italy, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Spain, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Spain, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Spain, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Eastern Europe, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Eastern Europe, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Eastern Europe, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Russia, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Russia, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Russia, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: North America, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: North America, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: North America, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: USA, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: USA, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: USA, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: Canada, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: Canada, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: Canada, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: South America, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: South America, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: South America, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Brazil, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Brazil, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Brazil, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Middle East, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Middle East, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Middle East, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Africa, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Africa, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Africa, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: AstraZeneca PLC Financial Performance
  • Table 76: Viatris Inc. Financial Performance
  • Table 77: Astellas Pharma Inc. Financial Performance
  • Table 78: Dr. Reddy's Laboratories Ltd. Financial Performance
  • Table 79: Hetero Drugs Limited Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Roxadustat Market, Segmentation By End-User Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Roxadustat Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Roxadustat Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Asia-Pacific, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Asia-Pacific, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Asia-Pacific, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: China, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: China, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: China, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: India, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: India, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: India, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: Japan, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: Japan, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Japan, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Australia, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Australia, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Australia, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Indonesia, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Indonesia, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Indonesia, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: South Korea, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: South Korea, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: South Korea, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Western Europe, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Western Europe, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Western Europe, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: UK, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: UK, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: UK, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Germany, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Germany, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Germany, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: France, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: France, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: France, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Italy, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Italy, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Italy, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Spain, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Spain, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Spain, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Eastern Europe, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Eastern Europe, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Eastern Europe, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Russia, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Russia, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Russia, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: North America, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: North America, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: North America, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: USA, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: USA, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: USA, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: Canada, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: Canada, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: Canada, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: South America, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: South America, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: South America, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Brazil, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Brazil, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Brazil, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Middle East, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Middle East, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Middle East, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Africa, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Africa, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Africa, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: AstraZeneca PLC Financial Performance
  • Figure 76: Viatris Inc. Financial Performance
  • Figure 77: Astellas Pharma Inc. Financial Performance
  • Figure 78: Dr. Reddy's Laboratories Ltd. Financial Performance
  • Figure 79: Hetero Drugs Limited Financial Performance

Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company

Read More

Global Gene Therapy Market 2022 – Market Opportunities And Strategies

Read More

The Microbiome Market Share, Market Size, And Growth Rate 2022

Read More

Latest TNF Alpha Inhibitors Market Growth Study 2022-2026 By The Business Research Company

Read More

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the hematology drugs market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the GI drugs market research report 2022 with industry size, share, segments and market growth

Read More

Anemia And Other Blood Disorder Drugs Global Market Report 2025 – By Type (Iron Deficiency Anemia, Chronic Kidney Disease Anemia, Sickle Cell Anemia, Aplastic Anemia), By Route of Administration (Oral, Injectable), By Distribution Channel (Hospitals Pharmacy, Online Pharmacy, Pharmacy) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Chemotherapy-Induced Anemia Global Market Report 2025 – By Anemia (Mild Anemia, Moderate Anemia, Severe Anemia, Life-Threatening Anemia), By Treatment Type (RBC (Red Blood Cells) Transfusion, Erythropoiesis-Stimulating Agents (ESAs), Iron Supplementation), By End-User (Hospitals, Ambulatory Surgical Centers, Multispecialty Clinics, Cancer Research Centers, Cancer Rehabilitation Centers) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Diabetic Kidney Disease Global Market Report 2025 – By Type (Type 1 Diabetes, Type 2 Diabetes), By Treatment (Angiotensin Receptor Blockers (Arbs), Angiotensin-Converting Enzyme (Ace) Inhibitors, Antioxidant Inflammation Modulator, Calcium Channel Blockers, Other Treatments), By End User (Hospitals, Homecare, Specialty Centers, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Kidney Transplant Global Market Report 2025 – By Transplant Type (Deceased-Donor Kidney Transplant, Living-Donor Kidney Transplant, Expanded Criteria Donor), By Age Group (Adult, Pediatrics), By Application (Drug Delivery, Capsule Endoscopy, Patient Monitoring), By End-User (Transplant Centers, Hospitals, Academic And Research Institutes) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Artificial Kidney Global Market Report 2025 – By Product Type (Wearable Artificial Kidney, Implantable Artificial Kidney ), By Dialysis (Hemodialysis, Peritoneal Dialysis, Combination), By End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Other End-User) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Rare Kidney Diseases Global Market Report 2025 – By Target Indication (IgA Nephropathy, Lupus Nephritis, Focal Segmental Glomerular Sclerosis, Membranous Nephropathy, C3 Glomerulopathy, Other Target Indications), By Type of Molecule ( Small Molecules, Biologics), By Route of administration (Oral, Intravenous, Subcutaneous, Other Routes of Administration) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Kidney Dialysis Global Market Report 2025 – By Type (Hemodialysis, Peritoneal Dialysis), By Product And Service (Equipment, Consumables, Dialysis Drugs, Services), By End-User (Home Care, Dialysis Centers And Hospitals, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Kidney Cancer Diagnostics And Therapeutics Global Market Report 2025 – By Cancer Type (Clear Cell RCC, Papillary RCC, Chromophobe RCC, Urothelial Carcinoma And Transitional Cell Carcinoma, Other Cancer Types), By Component (Drugs, Diagnostics), By Diagnostics (Biopsy, CT Scan, Nephro-ureteroscopy, Intravenous Pyelogram, Ultrasound), By Therapy (Targeted Therapy, Immunotherapy, Chemotherapy), By End-Users (Hospitals, Pharmaceutical Labs, Genomics Laboratories) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Roxadustat market?

Roxadustat is an orally administered hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI) that stabilizes hypoxia-inducible factors, leading to increased erythropoietin production, enhanced iron absorption, and improved hemoglobin synthesis without the need for exogenous erythropoiesis-stimulating agents. It is used to manage anemia by addressing low hemoglobin levels in patients with chronic kidney disease and potentially other conditions involving impaired red blood cell production. For further insights on the Roxadustat market, request a sample here

How will the Roxadustat market drivers and restraints affect the market dynamics? What forces will shape the Roxadustat industry going forward?

The Roxadustat market major growth driver - Impact Of Rising Chronic Kidney Disease Cases On The Growth Of The Market. For further insights on the Roxadustat market, request a sample here

What is the forecast market size or the forecast market value of the Roxadustat market?

The Roxadustat market size has grown strongly in recent years. The Roxadustat market size has grown strongly in recent years. It will grow from $6.44 billion in 2024 to $6.92 billion in 2025 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to regulatory approvals in major markets, strong clinical trial results, increasing prevalence of chronic kidney disease, growing awareness of anemia management, and government support for anemia treatments. The Roxadustat market size is expected to see strong growth in the next few years. It will grow to $9.16 billion in 2029 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to ongoing research for new indications, increasing healthcare expenditure, demand for non-injectable anemia treatments, expanding reimbursement policies, and rising geriatric population. Major trends in the forecast period include a shift towards oral anemia treatments, increasing competition from alternative therapies, expansion of licensing agreements, growing investment in hypoxia-inducible factor research, and a focus on patient-centric treatment approaches. For further insights on the Roxadustat market, request a sample here

How is the Roxadustat market segmented?

The roxadustat market covered in this report is segmented –
1) By Type: 20mg, 50mg
2) By Product Formulation: Oral Tablets
3) By Distribution Channel: Hospitals, Specialty Pharmacies, Dialysis Centers
4) By End-User Application: Chronic Kidney Disease-Associated Anemia, Other Anemia Conditions

Subsegments:
1) By 20mg: Oral Tablets, Injectable Formulations
2) By 50mg: Oral Tablets, Injectable Formulations For further insights on the Roxadustat market, request a sample here

Which region has the largest share of the Roxadustat market? What are the other regions covered in the report?

North America was the largest region in the Roxadustat market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the roxadustat market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Roxadustat market, request a sample here.

Who are the major players in the Roxadustat market?

Major companies operating in the roxadustat market are AstraZeneca PLC, Viatris Inc., Astellas Pharma Inc., Dr. Reddy's Laboratories Ltd., Hetero Drugs Limited, Akebia Therapeutics Inc., Metrochem API Private Limited, FibroGen Inc., AMI Lifesciences, Lee Pharma Ltd., Faran Shimi Pharmaceutical Company, Maithri Drugs Pvt. Ltd., Clearsynth Labs Ltd., Bal Pharma, HEMA Pharmaceuticals Pvt. Ltd., Zhejiang Hengkang Pharmaceutical Co. Ltd., Kimia Biosciences Pvt. Ltd., Lewens Labs Pvt. Ltd., Hangzhou Longshine Bio-Tech Co. Ltd., GLR Innovations, Suzhou Biosyntech Co. Ltd., Shanvr Life Sciences Pvt. Ltd. . For further insights on the Roxadustat market, request a sample here.

What are the key trends in the Roxadustat market?

Major trends in the Roxadustat market include Roxadustat Reimbursement Under Ireland’s High Tech Drugs Scheme Accelerates Market Growth. For further insights on the Roxadustat market, request a sample here.

What are the major opportunities in the Roxadustat market? What are the strategies for the Roxadustat market?

For detailed insights on the major opportunities and strategies in the Roxadustat market, request a sample here.

How does the Roxadustat market relate to the overall economy and other similar markets?

For detailed insights on the key dynamics influencing the Roxadustat market growth and SWOT analysis of the Roxadustat industry, request a sample here.

For detailed insights on Roxadustat's relation to the overall economy and other similar markets,

What are the latest mergers and acquisitions in the Roxadustat industry? request a sample here.

For detailed insights on the mergers and acquisitions in the Roxadustat industry,

What are the key dynamics influencing the Roxadustat market growth? SWOT analysis of the Roxadustat market. request a sample here.